One Of A Kind Trial To Test 14 AstraZeneca PLC, Pfizer Inc. Drugs At The Same Time
Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market.
Trending on the Topix Network
Wed Apr 16, 2014
UPDATE 1-Danske Bank fined by Nasdaq OMX over AstraZeneca share trading
The Nasdaq OMX stock exchange in Stockholm has fined Danske Bank 500,000 Swedish crowns for breaching trading rules in a placing of orders for shares in drugs company AstraZeneca, it said on Wednesday.
Mon Apr 14, 2014
AstraZeneca plc Rating Reiterated by Jefferies Group
's stock had its "hold" rating reaffirmed by stock analysts at Jefferies Group in a report issued on Monday, American Banking News.com reports.
Fri Apr 11, 2014
AstraZeneca plc Given Neutral Rating at Zacks
's stock had its "neutral" rating reaffirmed by Zacks in a note issued to investors on Friday, Stock Ratings Network reports.
Mon Apr 07, 2014
Starpharma Holdings Ltd Partners With Bio-Pharmaceutical Giant...
Starpharma Holdings has signed a second, expanded agreement with AstraZeneca in the field of cancer medicine using Starpharma's proprietary DEPa dendrimer drug delivery technology.
Sat Apr 05, 2014
Sell Ranbaxy And Buy AstraZeneca: Good Chance Nexium Generic Launch Delayed
AstraZeneca currently accounts for a Nexium generic entry in its annual guidance for FY-14 will benefit and revise its guidance upwards.
Thu Apr 03, 2014
AstraZeneca plc Receives "Neutral" Rating from Citigroup Inc.
's stock had its "neutral" rating reiterated by research analysts at Citigroup Inc. in a report released on Thursday, American Banking News.com reports.
Wed Apr 02, 2014
RDInvesting Provides Investors with Free In-Depth Equity Reports on...
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events.
Tue Apr 01, 2014
AstraZeneca plc Stock Rating Upgraded by Panmure Gordon
Shares of AstraZeneca plc traded up 0.70% on Tuesday, hitting $65.332. The stock had a trading volume of 503,244 shares.
AstraZeneca PLC Strikes Unique Deal To Work Side-By-Side With Medical ...
AstraZeneca PLC Strikes Unique Deal To Work Side-By-Side With Medical Research Council Scientists To Revitalize Pipeline, Spark Innovation AstraZeneca , a global innovation-driven pharmaceutical business, and the Medical Research Council have entered into a groundbreaking collaboration aimed at better understanding the mechanisms of human disease.
Mon Mar 31, 2014
AstraZeneca PLC Forms Collaboration With
Scientists from the Nephrology and Urology Center of Shenzhen University will put their academic and clinical skills together with the drug discovery/research expertise of AstraZeneca's Shanghai Innovation Center researchers.
Fri Mar 28, 2014
Endocyte Cancer Drug Is Prize Worth Top Premium: Real M&A
Now that Endocyte Inc.'s experimental cancer treatment is proving successful, the company may command a takeover bid at one of the industry's highest premiums on record.
Thu Mar 27, 2014
AstraZeneca's New Diabetes Drug May Also Combat Alzheimer's Disease
A relatively new diabetes drug, Symlin , developed by AstraZeneca's Amylin Pharmaceuticals has been found to combat a major component of Alzheimer's disease and may offer a new treatment option for the millions of Americans with the memory-robbing condition.
Wed Mar 26, 2014
AstraZeneca PLC Takes Full Control Of Japanese Unit, Buys Out...
AstraZeneca has raised its bet on Japan's drug market by buying out the remaining stake held by Sumitomo Chemical in its Japanese unit AstraZeneca K.K. The British group said on Wednesday the purchase of the shares cost approximately 10 billion yen and reinforced its focus on Japan as a key growth platform.
Tue Mar 25, 2014
AstraZeneca PLC Steps Up Hiring Spree Plans, Aims To Fill 1,500 Posts
AstraZeneca isn't the only one hiring, others are hiring too! Check it out! Pharma giant AstraZeneca is accelerating a recruitment drive as it steps up its move to Cambridge UK.
AstraZeneca PLC Ceo Gets a Bigger Bonus In 2013
AstraZeneca boss Pascal Soriot was awarded a bumper bonus for 2013, equivalent to 94 per cent of the maximum the pharmaceuticals giant could have paid its CEO.
Sat Mar 22, 2014
Packaging Operator Mechanic I
Thank you for your interest in the Packaging Operator Mechanic I. To begin the application process, please enter your information below.
Fri Mar 21, 2014
Health Care Sector Equities Technical Commentary -- Research on...
The gains were broad based as nine out of ten sectors posted gains. The S&P 500 Health Care Sector Index finished the day at 686.29, down 0.02%, while the same has gained 0.77% in the last one month.
Thu Mar 20, 2014
AstraZeneca proposes appointment of Ann Cairns as non-executive director
Ann will bring more than twenty years' in-depth financial and international business experience to the Board and we look forward to welcoming her.'